Novartis AG
Sacubitril-valsartan dosage regimen for treating heart failure
Last updated:
Abstract:
The present invention relates to sacubitril-valsartan dosage regimens for the treatment of heart failure in a patient.
Status:
Grant
Type:
Utility
Filling date:
9 May 2016
Issue date:
13 Jul 2021